Paul Mampilly is the editor of Professional Speculator, a monthly investment advisory focused on small growth stocks with huge upside potential, especially in the biotech and health care sectors. Although Paul is an exceptional long-term investor, his true passion and skill is speculating in the stock market. He's a master at pinpointing small companies with innovative business models and products, the kind that can soar 200%... 500%... even 1,000%-plus.